Oscar Lambret Center
Oscar Lambret Center
Lille, France1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults | Refractory or Recurrent Solid Tumor | Active, not recruiting | Phase 1 / Phase 2 | 2026-01-15 | NCT05210413 |